You are viewing: Europe Veterinary Contract Manufacturing & Research Market analysis

The Europe Veterinary Contract Manufacturing & Research Market was valued at $352.4 Million in 2026 and projected to reach to $503.5 Million by 2031, representing a compound annual growth rate of 7.4%. Europe's veterinary contract manufacturing and research market is experiencing steady expansion, fueled by increasing demand for specialized pharmaceutical and biological manufacturing services tailored to veterinary applications.

Europe Veterinary Contract Manufacturing & Research Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe Veterinary Contract Manufacturing & Research Market Trends and Insights

  • This growth trajectory in Europe is driven by increasing demand for specialized pharmaceutical and biological manufacturing services tailored to veterinary applications, alongside rising regulatory compliance requirements across European member states.
  • Europe's established pharmaceutical infrastructure and stringent quality standards position the region as a critical hub for contract manufacturing partnerships. The European market benefits from a robust network of contract research organizations (CROs) and manufacturing facilities equipped to handle complex formulations and clinical trial support.
  • Europe's commitment to animal health innovation and the presence of major veterinary pharmaceutical companies strengthen the competitive landscape.
  • Between 2026 and 2031, Europe is expected to capture significant market share as pet ownership rises and livestock health management becomes increasingly sophisticated across the continent..

Key Market Statistics

  • CAGR (2026-2031) 7.4% CAGR
  • Market Size, 2026 ~USD 352.4 Million
  • Forecast, 2031 ~USD 503.5 Million
  • Geography Europe

Europe Veterinary Contract Manufacturing & Research Market Overview

Market Valuation & Growth :

Europe's veterinary contract manufacturing and research market is valued at $352.4 million in 2026, with a projected expansion to $503.5 million by 2031, representing a robust 7.4% CAGR.

Germany's Market Leadership :

Germany dominates the European market with $132.6 million in market size, driven by advanced pharmaceutical manufacturing infrastructure and stringent regulatory compliance standards.

Regulatory Excellence & Compliance :

Europe's strong regulatory framework and emphasis on quality standards are driving demand for specialized veterinary pharmaceutical and biological manufacturing services across the region.

Multi-Country Growth Opportunity :

The UK ($99.5M), France ($78.6M), and Italy ($57.2M) represent significant secondary markets, collectively contributing substantial growth potential alongside Germany's leadership position.

Europe Veterinary Contract Manufacturing & Research Market Dynamics

  • The region's commitment to regulatory excellence and quality assurance standards positions it as a preferred destination for contract manufacturing partnerships.
  • Rising investments in veterinary healthcare infrastructure and growing pet ownership across European nations are amplifying demand for innovative veterinary pharmaceuticals and biologics.
  • By 2031, the market is expected to reach $503.5 million, reflecting sustained confidence in Europe's manufacturing capabilities and research competencies..

Related Ecosystem

Animal Health

Top Technologies
    Top Companies

      Key Takeaways

      • Europe's veterinary contract manufacturing market is valued at $352.4 million in 2026 and will grow to $503.5 million by 2031 at a 7.4% CAGR.
      • Europe's stringent regulatory environment and advanced pharmaceutical infrastructure make it a preferred destination for veterinary contract manufacturing partnerships.
      • Rising pet ownership and demand for specialized livestock health solutions are key growth drivers across Europe between 2026 and 2031.
      • Europe's established network of CROs and manufacturing facilities positions the region as a competitive hub for complex veterinary formulation development and clinical research.

      Veterinary Contract Manufacturing & Research Market Report Scope

      Report Metric Details
      Base Year 2026
      Fastest Growing Segment CDMO SERVICES (Service)
      Forecast Period 2026–2031
      Growth Rate CAGR of 7.7% from 2026 to 2031
      Largest Segment CDMO SERVICES (Service)
      Market Size Base Year (Billions) ~USD 6.38 (2026)
      Revenue Forecast (Billions) ~USD 9.24 (2031)
      Segments Covered Service, Type

      Europe Veterinary Contract Manufacturing & Research Market Report Segmentation

      2 segment dimensions are covered across the global market.

      By Service

      • Cdmo Services
      • Cro Services

      By Type

      • Analytical & Bioanalytical Services And Quality Assurance
      • Discovery & Pre-Clinical Studies
      • Manufacturing
      • Packaging & Labeling
      • Process Api & Formulation Development
      • Quality/Stability & Post-Market Support
      • Regulatory Affairs & Consulting
      • Veterinary Clinical Trials

      REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031

      Segment20242025202620272028202920302031CAGR (%)
      MID-SIZED/SPECIALTY ANIMAL HEALTH FIRMS15.816.91819.220.421.823.324.86.7
      MULTINATIONAL ANIMAL HEALTH COMPANIES21.822.823.925.126.327.628.930.34.9
      START-UPS & VETERINARY BIOTECH FIRMS6.16.67.27.98.69.410.311.29.2
      TOTAL43.646.249.152.155.358.862.466.46.2

      EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031

      Segment20242025202620272028202920302031CAGR (%)
      MID-SIZED/SPECIALTY ANIMAL HEALTH FIRMS129.5139.2150161.5174187.4202217.87.7
      MULTINATIONAL ANIMAL HEALTH COMPANIES132.8140.4148.6157.2166.5176.3186.7197.95.9
      START-UPS & VETERINARY BIOTECH FIRMS44.448.953.959.465.572.279.787.910.3
      TOTAL306.8328.5352.4378.1405.9435.9468.4503.57.4

      Target Audience

      • Contract Manufacturing Organizations (CMOs) : CMOs need European market data to identify expansion opportunities, benchmark competitive positioning, and develop targeted growth strategies in high-value veterinary segments.
      • Veterinary Pharmaceutical Companies : Veterinary pharma firms require regional market insights to optimize manufacturing partnerships, assess outsourcing opportunities, and plan product launches across European markets.
      • Private Equity & Investment Firms : Investors need comprehensive market analysis to evaluate acquisition targets, assess growth potential, and identify consolidation opportunities in Europe's veterinary manufacturing sector.
      • Regulatory & Compliance Consultants : Consultants require market intelligence to advise clients on European regulatory landscapes, manufacturing standards, and compliance requirements specific to veterinary applications.
      • Market Research & Strategy Teams : Corporate strategists need detailed European market data to support business planning, competitive analysis, and decision-making for veterinary healthcare investments and partnerships.

      Europe vs. other regions

      HowEurope compares to the other 3 regional blocs covered in this market.

      North America
      ~USD 579.5 Million · 8% wtd CAGR ·
      Asia Pacific
      ~USD 323.7 Million · 9.1% wtd CAGR ·

      Countries within Europe - compare and drill down

      Country2025 size (native)
      GermanyUSD 132.6 Million
      UKUSD 99.5 Million
      FranceUSD 78.6 Million
      ItalyUSD 57.2 Million
      SpainUSD 41.8 Million
      NetherlandsUSD 27.4 Million

      Country market size visualization

      Germany
      USD 132.6 Million
      UK
      USD 99.5 Million
      France
      USD 78.6 Million
      Italy
      USD 57.2 Million
      Spain
      USD 41.8 Million
      Netherlands
      USD 27.4 Million

      Reasons to Buy this Report

      • Regional Market Intelligence : Gain detailed insights into Europe's $352.4M veterinary contract manufacturing market with country-level breakdowns across Germany, UK, France, Italy, Spain, and Netherlands.
      • Growth Forecasting & Strategy : Access 5-year projections through 2031 showing 7.4% CAGR expansion to $503.5M, enabling informed strategic planning and investment decisions for European market entry.
      • Competitive Landscape Analysis : Understand market dynamics across Europe's leading pharmaceutical hubs, identifying opportunities in Germany's $132.6M market and emerging potential in secondary markets.
      • Regulatory & Compliance Insights : Navigate Europe's stringent regulatory environment with market analysis reflecting quality standards and compliance requirements driving veterinary manufacturing demand.
      • Investment & Partnership Opportunities : Identify high-potential markets and partnership targets across Europe's veterinary contract manufacturing ecosystem for expansion, acquisition, or collaboration strategies.

      Frequently asked questions

      What is the current market size of veterinary contract manufacturing in Europe?

      Europe's veterinary contract manufacturing and research market is valued at $352.4 million in 2026.

      What is the projected market size for Europe by 2031?

      Europe's veterinary contract manufacturing market is projected to reach $503.5 million by 2031.

      What is the growth rate for Europe's veterinary contract manufacturing market?

      Europe's veterinary contract manufacturing market is expected to grow at a compound annual growth rate (CAGR) of 7.4% from 2026 to 2031.

      Why is Europe a key market for veterinary contract manufacturing?

      Europe benefits from stringent regulatory standards, advanced pharmaceutical infrastructure, established CRO networks, and a strong presence of major veterinary pharmaceutical companies.

      What factors are driving growth in Europe's veterinary contract manufacturing market?

      Key drivers include rising pet ownership, increasing demand for livestock health solutions, regulatory compliance requirements, and innovation in veterinary pharmaceutical formulations across Europe.

      RESEARCH METHODOLOGY

      This research study extensively utilized both primary and secondary sources. It involved analyzing various factors that influence the industry to identify segmentation types, industry trends, key players, competitive landscape, key market dynamics, and the strategies employed by key players.

      Secondary Research

      This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the veterinary contract manufacturing & research market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments about both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

      Primary Research

      In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development, and operations managers, as well as presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the veterinary contract manufacturing & research market. Primary sources from the demand side include R&D scientists and researchers in animal health companies, veterinary clinicians, and veterinary biotech firms developing veterinary therapeutics and technologies.

      Veterinary Contract Manufacturing and Research Market 
 Size, and Share

      Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.
      Note 2: Other designations include sales, marketing, and product/service managers.

      Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The total size of the veterinary contract manufacturing & research market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

      Veterinary Contract Manufacturing and Research Market Top Down and Bottom Up Approach

      Data Triangulation

      After arriving at the veterinary contract manufacturing & research market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and obtain precise statistics for all segments and subsegments.

      Market Definition

      The veterinary contract research organization (CRO) market comprises third-party service providers that support animal-health companies in the outsourced research and development of veterinary pharmaceuticals, biologics, vaccines, and related products. Veterinary CROs provide services across the product lifecycle, including discovery support, preclinical studies, target animal safety, clinical field trials, bioequivalence studies, regulatory consulting, and post-approval research, in compliance with veterinary regulatory standards. These services are primarily used by animal-health pharmaceutical companies, biotechnology firms, and vaccine developers to reduce development timelines, access specialized expertise, manage regulatory complexity, and optimize R&D costs without maintaining a complete in-house research infrastructure. The veterinary contract development and manufacturing organization (CDMO) market consists of third-party manufacturers that provide outsourced development, scale-up, and commercial manufacturing services for veterinary drugs, biologics, vaccines, and related products. Veterinary CDMOs support animal-health companies through process and formulation development, API and finished dosage form manufacturing, fill-finish operations, packaging and labeling, quality control, stability testing, and regulatory manufacturing support, operating in accordance with veterinary GMP and biologics regulations.

      These services enable animal-health companies to outsource capital-intensive manufacturing activities, increase production flexibility, manage capacity constraints, and accelerate market entry, particularly for complex formulations, sterile injectables, and veterinary vaccines.

      Key Stakeholders

      • Animal-health pharmaceutical companies
      • Veterinary biotechnology companies
      • Veterinary biologics & vaccine developers
      • Veterinary contract development & manufacturing organizations (CDMOs)
      • Veterinary contract research organizations (CROs)
      • Preclinical & toxicology research laboratories (GLP & non-GLP)
      • Clinical trial management organizations for veterinary studies
      • Regulatory consulting firms specializing in VICH / EMA / FDA-CVM
      • Quality control & analytical testing laboratories (veterinary-focused)
      • Veterinary formulation & process development service providers
      • Packaging, filling, and labeling service providers for veterinary products
      • Animal research facilities & field trial centers
      • Veterinary academic research institutes
      • Livestock research institutions & herd-health trial networks
      • Raw material suppliers for veterinary APIs, excipients, and biologics components

      Report Objectives

      • To define, describe, segment, and forecast the veterinary contract manufacturing & research market by service, product type, animal type, end user, and region
      • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
      • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall veterinary contract manufacturing & research market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of the veterinary contract manufacturing & research market in five central regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
      • To profile the key players in the veterinary contract manufacturing & research market and comprehensively analyze their core competencies and market shares
      • To track and analyze competitive developments such as acquisitions, service launches, expansions, collaborations, agreements, and partnerships

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

      Company Information
      • Detailed analysis and profiling of additional market players (up to 5)

      Geographic Analysis

      • Further breakdown of the Rest of Europe veterinary contract manufacturing & research market into Austria, Finland, Switzerland, and other countries
      • Further breakdown of the Rest of Latin American veterinary contract manufacturing & research market into Colombia, Chile, and other countries
      Competitive Landscape Assessment
      • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the veterinary contract manufacturing & research market
      • Competitive leadership mapping for established players in the US

       

      Get the Full Veterinary Contract Manufacturing & Research Market Report

      Full forecast, segment splits, and company analysis for all Veterinary Contract Manufacturing & Research Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status